Loop diuretic treatment: time for new options
Keywords
loop diuretics
natriuresis
aldosterone
chronic heart failure
chronic kidney disease
Similar Articles
№2 / 2024
Kotenko O.N., Abolyan L.V., Kuteinikov V.Yu., Arsanukaev I.M., Dorofeeva E.G., Vinogradov V.E.
The results of a multifactorial analysis to identify medical and social factors associated with the quality of life of patients with chronic kidney disease on hemodialysis№1 / 2025
Levchenkova O.S., Novikov V.E., Vorobyeva V.V., Kozlov S.N.
Hif-prolylhydroxylase inhibitors: the future for anemia treatment in patients with chronic kidney disease№3 / 2025
Sokolova A.V., Dragunov D.O., Klimova A.V., Stafeeva E.A., Stafeev A.N., Golubev Ya.V., Shmigol T.A., Negrebetsky V.V., Arutyunov G.P.
Short-chain fatty acids as predictors of renal function decline in patients with sarcopenia and CHF№1 / 2025
Mikhailova L.V., Perepelitsa S.A., Struchkov S.T., Orlova Yu.A., Akchurina K.N.
Acute kidney injury in patients with COVID-19: severity of inflammatory response and risk of chronic kidney disease development№3 / 2024
Berdinsky V.A., Kotenko O.N., Frolova N.F., Vinogradov V.E., Kargalskaya I.G., Ivanova E.S., Dorofeeva E.G.
Improving health literacy in patients with CKD. Informed choice and collaborative decision making. Further patient education when choosing a peritoneal dialysis method


